Search results
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 4 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been...
Benzinga· 2 days agoPfizer Inc PFE reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. Goldman...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 4 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pfizer’s reported net income declines 44% in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer’s reported net income stood at $3.11bn in the first quarter (Q1) of 2024, marking a decrease of 44% from $5.54bn posted in Q1 2023. The...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 day agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Amazon, Pfizer, Pinterest rise premarket; AMD, Starbucks, CVS Health fall By Investing.com
Investing.com· 4 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 5 days agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 4 days agoPfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected,...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 3 days agoPfizer shares rose more than 6% Wednesday afternoon after the company's first-quarter results beat Wall Street analyst estimates and the drugmaker raised...